Accreditation

Target Audience

This conference is designed for physicians, infection preventionists, healthcare epidemiologists, infectious disease specialists, microbiologists, nurses, pharmacists, and other healthcare professionals interested in healthcare epidemiology, infection prevention, surveillance, research methods, patient safety, environmental issues and quality improvement.

The deadline to claim credit is October 16, 2025. Attendees must attend each selected session in its entirety to receive CME/CNE/CPE/MOC credit. Partial credit is not available. To claim CPE in-person session credit the deadline is May 30, 2025.

Accreditation Statements 

In support of improving patient care, The Society for Healthcare Epidemiology of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE (Interprofessional Continuing Education (IPCE) Credit):

This activity was planned by and for the healthcare team, and learners will receive 69.25 Interprofessional Continuing Education (IPCE) credit for learning and change. The SHEA Spring sessions are designated for 66.25 credit hours and the premeeting workshop is an additional 3.0.

CME (Continuing Medical Education): 

The Society for Healthcare Epidemiology of America designates this other activity (live course and internet enduring material activity) for a maximum 69.25 AMA PRA Category 1 Credits™. The SHEA Spring sessions are designated for 66.25 credit hours and each premeeting workshop is an additional 3.0. Physicians should claim only the credit commensurate with the extent of their participation in the activity. All CME-accredited sessions are also available for attendees to earn the American Board of Internal Medicine’s Maintenance of Certification (MOC) points.

MOC (Maintenance of Certification): 

Successful completion of this CME activity enables the participant to earn up to 69.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

CNE (Continuing Nursing Education):

A total of 69.25 ANCC contact hours will be available. The SHEA Spring sessions are designated for 66.25 credit hours and the premeeting workshop is an additional 3.0.

CPE (Continuing Pharmacy Education):

CPE Accreditation Statement for Pharmacists
The continuing education activity for pharmacists has been developed by the Society for Healthcare Epidemiology of America.  ACPE Universal Activity Number is UAN JA0006047-0000-24-003-L01-P for live knowledge-based sessions and UAN JA0006047-0000-24-003-H01-P for on demand knowledge-based sessions. This conference is acceptable for a maximum of 39.0 live CPE contact hours , and a maximum of 39.0 on-demand CPE contact hours in states that recognize ACPE providers. CPE will be available for the SHEA Antibiotic Stewardship Training Course and select few Full Conference Sessions. The registration fee covers the cost of CE credits. CE Statements of Completion will be issued by the Society for Healthcare Epidemiology (SHEA) at the conclusion of the conference. Participants must complete an evaluation for each session they attended to receive pharmacy CE credit. The deadline for completing the evaluations for the live CE sessions is May 30, 2025. SHEA will upload all SHEA Spring CPE credits to NABP CPE Monitor accounts within 30 days of completion for live CE sessions, and within 60 days of completion for on-demand sessions through October 16, 2025. 

Register!

Post-Conference Session Recordings
Session Recordings of the program will be complimentary for all attendees. Recordings will be available on-demand directly following the conference. Recordings will not be available for purchase. If you wish for access to the recordings, you must register for the conference. Credit for recordings will be available to watch until October 16, 2025.

Learning Objectives 

SHEA’s overall goal for SHEA Spring 2025 is for participants to gain valuable knowledge about the latest research and science in healthcare epidemiology and antimicrobial stewardship, practical skills and strategies to implement this knowledge, and ongoing connections with other professionals in the field of healthcare epidemiology, infection prevention, and antibiotic stewardship. At the conclusion of this activity, participants should be able to:

  • Evaluate new scientific evidence related to epidemiologic methods and prevention of outbreaks as well as healthcare-associated infections (HAIs)  and assess new data in controversial areas with sparse or inconclusive evidence.
  • Determine the impact of, and advocate for, public policy development including antiracism efforts, on healthcare epidemiology, infection prevention and antibiotic stewardship.
  • Incorporate the best methods in healthcare epidemiology, antibiotic stewardship, surveillance, prevention, and research into practice.
  • Adapt best practices and approaches to a variety of settings including acute care, long term care and pediatrics in collaboration with infection preventionists, pharmacists, microbiologists, nurses and other healthcare team members.  
  • Apply practical strategies and interprofessional team approaches to effectively communicate healthcare epidemiology, HAI prevention, and antimicrobial stewardship knowledge and practices to patients, healthcare personnel and policy makers
  • Describe the environmental impact of infection prevention and antimicrobial stewardship activities

SHEA/CDC Training Course in Healthcare Epidemiology 

At the conclusion of this activity, participants should be able to: 

  • Review the process of surveillance for healthcare-associated infections and how to apply surveillance techniques and methods within your healthcare team.
  • Define modes of transmission and approaches to prevention and control of healthcare-associated infections and antimicrobial-resistant pathogens, as well as other emerging infections in the healthcare setting.
  • Determine the roles that the environment, cleaning, disinfection, and sterilization play in the cycle of transmission of infections to patients.
  • Assess how infection prevention activities align with the disciplines of Healthcare Quality and Safety.
  • Apply and define outbreak investigation techniques and evidence-based infection prevention strategies.
  • Evaluate the unique approaches to infection prevention among special populations.
  • Determine the role of leadership and clinical education in infection prevention efforts.
  • Analyze the role of the healthcare epidemiologist in occupational health, epidemiology research, the microbiology laboratory and diagnostic stewardship, regulatory, and emergency preparedness.

SHEA Antibiotic Stewardship Training Course 

At the conclusion of this activity, participants should be able to: 

  • Incorporate effective strategies for partnering with key stakeholders and others to champion stewardship.
  • Develop and implement effective antimicrobial stewardship programs strategies within a variety of healthcare settings, including low resource settings.
  • Track, and report both process and outcome measures to quantify the impact of stewardship programs.
  • Network with and learn from antimicrobial stewardship colleagues from other institutions.
Register Today!

Financial Disclosures:

The Society for Healthcare Epidemiology (SHEA), in accordance with Joint Accreditation requirements and ACCME’s new Standards for Integrity and Independence in Accredited Continuing Education, requires everyone who is in a position to control the content of an accredited educational activity to disclose all financial relationships with any ineligible companies (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). The ACCME defines financial relationships as financial relationships in any amount occurring within the past 24 months that exists between the person in control of content and an ineligible company.

Faculty are required to either disclose financial relationships (name of ineligible company and nature of relationship) and include a statement that all relevant financial relationships have been mitigated or indicate that there are no relevant financial relationships. Disclosure to learners must not include ineligible companies’ corporate or product logos, trade names, or product group messages.

SHEA is responsible for ensuring that all CE-accredited activities are fair and balanced, and any clinical content presented supports safe, effective patient care. SHEA must also ensure all decisions related to the planning, faculty selection, delivery, and evaluation of accredited education are free from commercial bias and made without any influence or involvement from the owners and employees of an ineligible company.

Mitigation of Financial Conflicts of Interest

It is the policy of SHEA, in accordance with Joint Accreditation requirements and ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, that all faculty/speakers/moderators financial disclosures are mitigated prior to planning the educational content.  

SHEA faculty/speakers/moderators are required to agree to the following methods of mitigating relevant conflicts of interest(s) prior to the beginning of planning the educational content.  

  • If participating in the development of educational content, to refrain from developing those components of the course that support or promote any financial relationship(s) with ineligible companies.
  • To disclose any financial relationship(s) and include a statement that all relevant financial relationships have been mitigated in the course description, or that there are no conflicts of interest to disclose.
  • To use generic names of products and/or services.
  • If trade names of products and/or services are used, to use trade names from several companies, not just trade names from a single company.
  • Attest that clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).